No definition available.
Immunodeficiency with predominantly antibody defects
DOID EFO Endpoint Browser PheWeb
D3_IMMUDEFANTIBODY
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
---|---|
Phenotype data |
473681 |
1. Apply sex-specific ruleNone |
473681 |
2. Check conditionsNone |
473681 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
850 |
4. Check minimum number of eventsNone |
850 |
5. Include endpoints |
872 |
6. Filter based on genotype QC (FinnGen only) |
830 |
Control definitions (FinnGen only)
Extra metadata
Similar endpoints
↥List of similar endpoints to Immunodeficiency with predominantly antibody defects based on the number of shared cases.
Similar with more cases:
- Immunodeficiencies
- Certain disorders involving the immune mechanism
- Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism
- Any event in hilmo or specialist outpatient
- Any prescribed medicine buy
Similar with less cases:
Case counts by codes
↥Summary Statistics
↥-FinRegistry-
Key figures
All | Female | Male | |
---|---|---|---|
Number of individuals | |||
Whole population | 4354 | 2534 | 1806 |
Only index persons | 3907 | 2323 | 1584 |
Unadjusted period prevalence (%) | |||
Whole population | 0.06 | 0.07 | 0.05 |
Only index persons | 0.08 | 0.09 | 0.06 |
Median age at first event (years) | |||
Whole population | 41.53 | 44.86 | 36.81 |
Only index persons | 41.99 | 45.45 | 36.90 |
-FinnGen-
Key figures
All | Female | Male | |
---|---|---|---|
Number of individuals | 830 | 550 | 280 |
Unadjusted period prevalence (%) | 0.19 | 0.22 | 0.14 |
Median age at first event (years) | 48.51 | 47.08 | 51.34 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
Mortality – FinRegistry
↥Association
Association between endpoint D3_IMMUDEFANTIBODY and mortality.
Females
Parameter | HR [95% CI] | p-value |
---|---|---|
D3_IMMUDEFANTIBODY | 2.903 [2.37, 3.55] | < 0.001 |
Birth year | 0.996 [0.99, 1.0] | 0.301 |
During the follow-up period (1.1.1998 — 31.12.2019), 305 out of 2102 females with D3_IMMUDEFANTIBODY died.
Males
Parameter | HR [95% CI] | p-value |
---|---|---|
D3_IMMUDEFANTIBODY | 2.794 [2.15, 3.63] | < 0.001 |
Birth year | 0.983 [0.97, 0.99] | < 0.001 |
During the follow-up period (1.1.1998 — 31.12.2019), 231 out of 1401 males with D3_IMMUDEFANTIBODY died.
Mortality risk
Mortality risk for people of age
years, who have D3_IMMUDEFANTIBODY.N-year risk | Females | Males |
---|---|---|
1 | 0.329% | 0.461% |
5 | 1.814% | 2.947% |
10 | 4.576% | 7.651% |
15 | 8.876% | 13.489% |
20 | 14.553% | 22.313% |
Relationships between endpoints
↥Index endpoint: D3_IMMUDEFANTIBODY – Immunodeficiency with predominantly antibody defects
GWS hits: -